Drug approval
25 February 2002 00:00 [Source: ICB]
Air Liquide Santé has received French drug approval for its medical gas Kinox - a mixture of medical nitric oxide and nitrogen used for breathing. Its selective pulmonary vasodilation action makes it suitable for treating pulmonary arterial hypertension, says the company.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|
Subscribe Today Sample issue >> My Account/Renew >> Register for online access >> |
| ICIS Top 100 Chemical Companies |
|
|
Related Articles
- 11 Apr 11 12:00 GeNO LLC receives additional patent for inhaled Nitrosyl nitric oxide product
- 28 Mar 11 12:00 GeNO LLC initiates study of inhaled Nitrosyl nitric oxide in idiopathic pulmonary fibrosis (PH-IPF) and pulmonary arterial hypertension (PAH) patients
- 21 Dec 10 12:00 GeNO LLC initiates Phase II trial for nitric oxide delivery system
- 08 Dec 10 12:00 FDA clears GeNO LLC's Investigational New Drug application for clinical trials with its Nitrosyl Inhaled Nitric Oxide System
- 11 Nov 10 12:00 GeNO LLC submits investigational new drug application for its NITROsyl inhaled nitric oxide system to treat chronic pulmonary hypertension
- 17 Mar 03 00:00 Drug Delivery Market Looks To Deliver Results
- 04 Mar 02 00:00 Air Liquide Sante: drug approval.
Latest News
- 20 Jun 13 07:36 India’s IOC offers 6,000-9,000 tonnes Group I base oils
- 20 Jun 13 06:34 China’s Lanzhou Petchem shuts MEK plant on feedstock shortage
- 20 Jun 13 06:00 VIDEO - ICIS Asia Lunchtime Bulletin 20 June 2013
- 20 Jun 13 05:44 On-purpose technology can fill up by-product shortages: Booz & Co
- 20 Jun 13 05:28 Shale boom causing disruptions in by-product supply, prices